rs772011426
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP5_Moderate
The NM_001252024.2(TRPM1):c.1089+3_1089+6delAAGT variant causes a splice region, intron change. The variant allele was found at a frequency of 0.00000753 in 1,461,694 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000075 ( 0 hom. )
Consequence
TRPM1
NM_001252024.2 splice_region, intron
NM_001252024.2 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.17
Genes affected
TRPM1 (HGNC:7146): (transient receptor potential cation channel subfamily M member 1) This gene encodes a member of the transient receptor potential melastatin subfamily of transient receptor potential ion channels. The encoded protein is a calcium permeable cation channel that is expressed in melanocytes and may play a role in melanin synthesis. Specific mutations in this gene are the cause autosomal recessive complete congenital stationary night blindness-1C. The expression of this protein is inversely correlated with melanoma aggressiveness and as such it is used as a prognostic marker for melanoma metastasis. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 15-31062572-CACTT-C is Pathogenic according to our data. Variant chr15-31062572-CACTT-C is described in ClinVar as [Pathogenic]. Clinvar id is 30364.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr15-31062572-CACTT-C is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRPM1 | NM_001252024.2 | c.1089+3_1089+6delAAGT | splice_region_variant, intron_variant | ENST00000256552.11 | NP_001238953.1 | |||
TRPM1 | NM_001252020.2 | c.1140+3_1140+6delAAGT | splice_region_variant, intron_variant | NP_001238949.1 | ||||
TRPM1 | NM_002420.6 | c.1023+3_1023+6delAAGT | splice_region_variant, intron_variant | NP_002411.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRPM1 | ENST00000256552.11 | c.1089+3_1089+6delAAGT | splice_region_variant, intron_variant | 1 | NM_001252024.2 | ENSP00000256552.7 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 249332Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135280
GnomAD3 exomes
AF:
AC:
4
AN:
249332
Hom.:
AF XY:
AC XY:
2
AN XY:
135280
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461694Hom.: 0 AF XY: 0.00000413 AC XY: 3AN XY: 727158
GnomAD4 exome
AF:
AC:
11
AN:
1461694
Hom.:
AF XY:
AC XY:
3
AN XY:
727158
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Congenital stationary night blindness 1C Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 12, 2010 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | This sequence change falls in intron 8 of the TRPM1 gene. It does not directly change the encoded amino acid sequence of the TRPM1 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs772011426, gnomAD 0.01%). This variant has been observed in individual(s) with congenital stationary night blindness (PMID: 20300565; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as IVS8+3_6delAAGT. ClinVar contains an entry for this variant (Variation ID: 30364). Studies have shown that this variant alters TRPM1 gene expression (PMID: 20300565). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: 7
Find out detailed SpliceAI scores and Pangolin per-transcript scores at